MARES Commercializing Advanced Therapies & Technology scouting Turning Innovation into Products 1) We support biotech/pharmaceutical companies in commercializing advanced-therapy medicinal products (ATMPs). Gene- and cell therapeutics as well as tissue-engineered products offer fundamentally new treatment opportunities for unmet medical needs. In Europe, such products are called "Advanced-Therapy Medicinal Products", or ATMPs, denoting them to be a third class of medicinal products in addition to drugs and medical devices. To market such products in the EU, a market of 500 million people, specific regulatory, quality and process parameters have to be observed. 2) Technology Scouting/Tech Transfer -Companies need a constant stream of novel technologies to keep their portfolios up to date and to develop new products -Universities produce novel technologies and need to find interested companies. Mares Ltd connects companies and universities, manages the interaction and milestone-driven projects.